RLMD icon

Relmada Therapeutics

Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$9
154% upside
High target

3 analyst ratings

positive
neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside
Date
Leerink Partners
Leerink Partners
Andrew Berens
0% 1-yr RLMD win rate
23 Jan ‘26 9 days ago
Jefferies
Jefferies
Farzin Haque
0% 1-yr RLMD win rate
22 Dec ‘25 1 month ago
Mizuho
Mizuho
Uy Ear
0% 1-yr RLMD win rate
19 Nov ‘25 2 months ago